PIP
TMDX icon

Palisades Investment Partners’s Transmedics TMDX Stock Holding History

Palisades Investment Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-160,108
Closed -$9.98M – 43
2024
Q4 		$9.98M Buy
160,108
+11,323
+8% +$1.05M 4.21% 7
2024
Q3 		$23.4M Buy
148,785
+9,048
+6% +$1.39M 10.17% 1
2024
Q2 		$21M Buy
+139,737
New +$16.8M 10.42% 1

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Palisades Investment Partners's TMDX Position: Q1 2025 in Review

Palisades Investment Partners sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 160,108 shares — an estimated $9.98M sold.

Palisades Investment Partners first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $23.4M in Q3 2024. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Palisades Investment Partners reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Palisades Investment Partners sold 160,108 Transmedics shares in Q1 2025, an estimated $9.98M.
  • Palisades Investment Partners first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
  • Palisades Investment Partners's Transmedics position peaked at $23.4M in Q3 2024.
  • 299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Palisades Investment Partners's 13F filing for Q1 2025, filed 30 Apr 2025.